Compositions and methods for cell energy using combination of fisetin and quercetin

CN119072309APending Publication Date: 2024-12-03SOCIETE DES PRODUITS NESTLE SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380035794.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-05-17
Filing Date
2023-05-16
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

With the aging population, cognitive function decline and physical decline are common among middle-aged and elderly people. The existing technology lacks effective pharmacological compounds to regulate mitochondrial Ca2+ homeostasis, resulting in oxidative stress and metabolic decline.

Method used

The composition of ferresin and quercetin is provided, which enhances mitochondrial function by activating mitochondrial calcium unidirectional transporters, improves cell energy production efficiency, reduces oxidative stress, delays metabolic decline, and maintains cognitive and muscle function.

Benefits of technology

It significantly improves the intracellular mitochondrial energy and calcium uptake ability, enhances antioxidant ability, delays metabolic decline, maintains cognitive and muscle function, and effectively prevents or treats calcium deficiency disorders and metabolic fatigue.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0005097556160000011
    Figure HDA0005097556160000011
  • Figure HDA0005097556160000021
    Figure HDA0005097556160000021
  • Figure HDA0005097556160000031
    Figure HDA0005097556160000031
Patent Text Reader

Abstract

The present invention provides compositions comprising a combination of fisetin and / or a derivative thereof and quercetin or a derivative thereof. The composition may be an oral nutritional composition, such as a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical use (FSMP). The composition may be administered to a subject in need thereof for improving a physiological state associated with metabolic fatigue in one or more cells in a subject, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress, and / or enhancing mitochondrial function, such as metabolic fatigue in one or more cells, in a subject. (iv) treating or preventing calcium deficiency / depletion disorders. Additionally or alternatively, the methods may treat or prevent a disease or condition associated with mitochondrial or associated with altered mitochondrial function in an individual in need thereof or at risk thereof.
Need to check novelty before this filing date? Find Prior Art